• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 41 of 100
Biogen Alzheimers Drug Data
NewslettersThe Broader Implications of Biogen’s Divisive Alzheimer’s Drug
By Sy MukherjeeDecember 5, 2019
Diabetes medicine pills
HealthFDA Is Testing Diabetes Drug Metformin for NDMA, a Carcinogen
By John Lauerman and BloombergDecember 4, 2019
Astellas Gene Therapy Deal
NewslettersThe Gene Therapy Spree Rolls on With $3 Billion Astellas Deal
By Sy MukherjeeDecember 3, 2019
Biogen Stock Alzheimer's Aducanumab
NewslettersBiogen Stock Falls After Analyst Throws Cold Water on Its Alzheimer’s Drug Bet
By Sy MukherjeeDecember 2, 2019
A boy suffering from dengue fever rests under a mosquito net in a gymnasium
MagazineEpidemic of fear: How the trouble-ridden debut of a breakthrough vaccine sparked a panic
By Erika FryNovember 26, 2019
Novartis Amarin Cholesterol Drugs
NewslettersNovartis’ $9.7 Billion Deal Sets off Heart Drug Wars
By Sy MukherjeeNovember 25, 2019
American Vasant Narasimhan, CEO of Swiss pharmaceutical and drug maker Novartis speaks during a conference at the Fortune Global Forum event in Paris on Nov. 18, 2019. (Photo by ERIC PIERMONT / AFP) (Photo by ERIC PIERMONT/AFP via Getty Images)
FinanceNovartis Bets Big on Cholesterol Drug With $9.7 Billion Buyout of Medicines Co.
By James Paton and BloombergNovember 25, 2019
Best Drugs Last 10 Years
NewslettersWhich Medicines Have Transformed Drug Development in the Past Decade?
By Sy MukherjeeNovember 22, 2019
Fish Oil Drug to Treat Heart Disease Gets Key Nod for Wider FDA Approval
PoliticsFish Oil Drug to Treat Heart Disease Gets Key Nod for Wider FDA Approval
By Matthew Perrone and The Associated PressNovember 15, 2019
BeiGene FDA Approval Cancer
NewslettersChinese Biotech BeiGene Makes a Splash in Cancer Treatment With FDA Drug Approval
By Sy MukherjeeNovember 14, 2019
CRISPR Gene Editing Cancer Safety
NewslettersCRISPR Gene-Editing Is Being Used to Fight Cancer—And May Be Safe
By Sy MukherjeeNovember 7, 2019
Trump Breaks From Pelosi Medicare Drug Talks, Throws Support Behind Senate Bill
PoliticsTrump Breaks From Pelosi Medicare Drug Talks, Throws Support Behind Senate Bill
By Ricardo Alonso-Zaldivar and The Associated PressNovember 5, 2019
The Hong Kong skyline is shown at night in a layer of cloudy fog.
FinanceThis 24-Year-Old Chinese Biopharma Heir Just Became an Overnight Billionaire
By Blake Schmidt, Venus Feng, Gregor Stuart Hunter and BloombergOctober 23, 2019
Biogen Alzheimers Aducanumab
NewslettersLet’s Talk About Biogen’s Stunning Alzheimer’s Drug Reversal: Brainstorm Health
By Sy MukherjeeOctober 22, 2019
fortune logo icon (red)
NewslettersCould Lowering Drug Prices Hamper Drug Innovation?—Brainstorm Health
By Sy MukherjeeOctober 14, 2019
1...
  • 39
  • 40
  • 41
  • 42
  • 43
...100
Most Popular
Politics
'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuzplaceholder alt text
By Fortune EditorsApril 11, 2026
Economy
'People are trying to be creative': Tariff-battered American companies are so cash-starved they are using refund claims as collateral for loansplaceholder alt text
By Fortune EditorsApril 12, 2026
Real Estate
A 93-year-old refused to sell her home to the Masters golf course that’s spent $280 million on expansion: ‘Money ain’t everything’placeholder alt text
By Fortune EditorsApril 12, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.